CAS 952652-79-8

Formel: C23H27N5O3

InChl: InChI=1S/C23H27N5O3/c1-4-7-20(29)28(21(15(2)3)23(30)31)14-16-10-12-17(13-11-16)18-8-5-6-9-19(18)22-24-26-27-25-22/h5-6,8-13,15,21H,4,7,14H2,1-3H3,(H,30,31)(H,24,25,26,27)/t21-/m0/s1

InChI Key: OKAQHVJSXLGXET-NRFANRHFSA-N

SMILES: CCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O

Valsartan Related Compound B

CAS: 952652-79-8

Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi

Formel: C₂₃H₂₇N₅O₃

Farbe und Form: White Powder

Molekulargewicht: 421.21139

Ref: 45-1708784

(S)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)butyramido)-3-methylbutanoic acid

CAS: 952652-79-8

(S)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)butyramido)-3-methylbutanoic acid

Formel: C₂₃H₂₇N₅O₃

Reinheit: 98%

Molekulargewicht: 421.49

Ref: 54-OR1124846

(S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)butyramido)-3-methylbutanoic acid

CAS: 952652-79-8

Formel: C₂₃H₂₇N₅O₃

Reinheit: 95%

Farbe und Form: Solid

Molekulargewicht: 421.4922

Ref: IN-DA00IIWL

Valsartan EP Impurity C (Valsartan USP Related Compound B)

CAS: 952652-79-8

Formel: C₂₃H₂₇N₅O₃

Farbe und Form: Off-White Solid

Molekulargewicht: 421.50

Ref: 4Z-V-026

(2S)-2-[Butanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutanoic Acid

CAS: 952652-79-8

Farbe und Form: Neat

Ref: 86-MM0487.04

Valsartan n-Propyl Impurity

Kontrolliertes Produkt

CAS: 952652-79-8

Impurity Valsartan Related Compound B
Applications Valsartan n-Propyl is an impurity in the synthesis of Valsartan (V095750). Valsartan USP Related Compound B.
References Hillaert, S., et al.: J. Pharm. Biomed. Anal., 31, 329 (2003), Carlucci, G., et al.: Anal. Lett., 33, 2491 (2000), Cagigal, E., et al.: Talanta, 54, 1121 (2001),

Formel: C₂₃H₂₇N₅O₃

Farbe und Form: Neat

Molekulargewicht: 421.49

Ref: TR-V095770

Valsartan Impurity 46

CAS: 952652-79-8

Formel: C₂₅H₃₁N₅O₃

Farbe und Form: Off-White Solid

Molekulargewicht: 449.56

Ref: 4Z-V-0268

Valsartan EP Impurity C

CAS: 952652-79-8

Formel: C₂₃H₂₇N₅O₃

Molekulargewicht: 421.49

Ref: ST-EA-CP-V3003

(S)-N-Butyryl-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]valine

CAS: 952652-79-8

(S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)butyramido)-3-methylbutanoic acid

Formel: C₂₃H₂₇N₅O₃

Reinheit: 98%

Molekulargewicht: 421.49

Ref: IN-DG164353

N-(1-Oxobutyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine

CAS: 952652-79-8

N-(1-Oxobutyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine (GW1929) is a potent vasodilator that is used for the treatment of hypertension. It is synthesized by condensation of sodium hydroxide with 2-(4′-chlorophenyl)piperazine followed by methyl esterification and chloride acylation. The synthesis of GW1929 has been accomplished in two steps: carbonate cyclization and valsartan hydrolysis. In the first step, the carboxylic acid group of GW1929 was converted to its corresponding chloride compound which was then reacted with methyl bromide to yield the desired product. The second step involved hydrolysis of GW1929 with potassium carbonate, after which it was oxidized with azide to form an ester. Sodium

Formel: C₂₃H₂₇N₅O₃

Reinheit: Min. 95%

Farbe und Form: White Powder

Molekulargewicht: 421.49 g/mol

Ref: 3D-IO28664